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Abstract—Uniform heating of tumor tissue to therapeutic temperatures without damaging
surrounding normal tissue is required for optimal local heat therapy of cancer. This paper
describes an algorithm for online computer control that will allow the therapist to minimize the
standard deviation of measured intratumoral temperatures. The method is applicable to systems
incorporating multiple surface and/or interstitial applicators delivering microwave,
radiofrequency, or ultrasonic power and operating under the control of a small computer. The
essential element is a novel predictive-adaptive control algorithm that infers relevant thermal
parameters from the responses of multiple temperature sensors, as each of the power applicators
is briefly turned off. Applied power and effective perfusion are estimated from transient slope
changes of the temperature-time curves for each sensor. By substituting these values into a
system of linear equations derived from the bio-heat transfer equation, the small computer can
calculate the optimal allocation of power among the various applicators (“knob settings”) to
generate most uniform intratumoral temperature distribution with the desired mean, or minimum,
tumor temperature.
Key words: Hyperthermia, computer control, treatment planning, multipoint feedback control.
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NOMENCLATURE
Subscripts
i = l, 2, 3,. k

denote external or interstitial applicators, each at a fixed position in space.

j = l, 2, 3,..n

denote points in the tumor at which temperature, applied power density, and
effective perfusion are measured and for which predicted temperatures are
calculated.

Fundamental Variables

Pi, j

estimated power density (SAR) that would be generated at point j, assuming all power is
delivered via applicator i.

i

fraction of total power delivered through applicator.

Pj

net predicted power at point j from all applicators   i Pj .

k

i 1

j

apparent perfusion (SCR) at point j calculated from thermal washout.

t

diagnostic cycle time.

Tj

temperature rise at point j.

Derived Variables

Tj0

temperature rise above arterial temperature at measuring point j at beginning of next
diagnostic cycle = end of current diagnostic cycle.

j

 0.5jcb t /(c) , a dimensionless dummy variable related to heat loss during the
diagnostic cycle.

di,j

 t /(c)Pi, j  (1   j ) , a dummy variable with units of temperature.

T

mean predicted temperature rise for all measuring points 1 to n.

T 0 

mean initial temperature rise for all measuring points 1 to n at beginning of next
diagnostic cycle.
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di

mean value of di,j for all points j = 1 to n, a dummy variable associated with each
applicator.

r

power multiplier; total power required to achieve target temperature at end of next
diagnostic cycle divided by total power of current diagnostic cycle.

I. INTRODUCTION
During local heat therapy for a circumscribed tumor mass, the therapist strives to elevate
intratumoral temperature uniformly to a therapeutic, tumor killing level while maintaining
surrounding normal tissue at a safe, nonlethal temperature. In the ideal limiting case, the
temperature distribution in space would approach a step function, abruptly rising to a constant
therapeutic level at the tumor edge (Fig. 1). It is useful to describe such an ideal temperature
distribution as having two essential properties:
(1)

A clear separation of the mean intratumoral temperature from the mean temperature of
surrounding normal tissue during treatment.

(2)

Minimum spatial variation in intratumoral temperatures.

The first property describes selectivity of heating; the second property describes uniformity of
heating.
An effective biological means for enhancing the selectivity of local heat treatment is through the
use of vasodilator drugs, which favorably alter the partitioning of blood flow between tumor and
surrounding normal tissue [1]-[3]. Complementary technological means of enhancing selectivity
include schemes for focusing power deposition within the tumor mass, such as multiple
ultrasonic beams or interstitial microwave antennas [4]-[6].
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Fig. 1. Concept of ideal local heat therapy for a circumscribed lesion. Tumor temperature is
uniformly elevated with respect to surrounding normal tissue. The variability of intratumoral
temperatures is nil.
There remains, however, the problem of achieving maximal uniformity of tumor temperatures.
Some method is needed to adjust power in the multiple applicators to avoid treatment failures
associated with cold spots in the tumor, as well as possible complications associated with hot
spots within the treatment field. The present paper describes a predictive-adaptive control
algorithm that enhances the uniformity of intratumoral temperature distributions by favorably
adjusting and continually readjusting the proportion of power applied to various surface and/or
interstitial applicators during the course of a treatment session.
II. COMPUTATIONAL METHODS
The computational approach we present for predictive-adaptive, multipoint feedback control of
multi-applicator hyperthermia systems has three major aspects. The first is the means by which a
microcomputer can estimate applied power density and “effective perfusion” from temperature
data recorded from each of several temperature probes embedded in the tissue. The second is the
means by which the computer can repeatedly calculate the optimal partitioning of total power
among the various applicators by solving a set of simultaneous, linear equations. The third is the
means by which total power is then scaled to achieve the desired mean (or minimum)
intratumoral temperature.
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A. Real-Time Estimation of Thermal Parameters
Previous reports have described the well-known technique in which, assuming that initial tissue
temperature is stable and equal to arterial blood temperature, specific absorption rate (SAR) of
applied energy (i.e., power) can be estimated from the slope of the temperature-time curve
during a brief period of heating, according to the expression

where  is tissue density, c is tissue specific heat, T is temperature, and t is time [1], [7]. It is
equally true, however, from inspection of the bio-heat equation, that if at any time during tissue
heating power is suddenly turned off, the SAR just prior to turn-off must be equal to the resultant
slope change, i.e.,

A hyperthermia treatment usually lasts 30 to 60 min. The time required to monitor slope changes
after power-off is roughly 30 sec, an interval typically short with respect to thermal time
constants in tissue. The specific contribution of each applicator to the net SAR can be obtained
by analysis of the effect upon temperature at each monitored location caused by turning the
power to the applicator off for about 30 sec. In a similar way, “effective perfusion” or “specific
cooling rate” (SCR) can be determined from the slope of the temperature-time curves at each
monitored site when all power is briefly turned off, using the expression

where cb is the blood specific heat and T is the tissue temperature rise above arterial
temperature. We refer to the process of measuring the power contribution of each applicator and
the effective perfusion at each site as a diagnostic cycle. Since the distribution of perfusion
(typically the dominant component of SCR) in adjacent normal tissues changes during the
hyperthermia treatment, and since power will be deliberately changed under computer control, it
is necessary to repeat the diagnostic cycle continually to obtain updated values. In this way, the
essential heat transfer parameters for predictive control of the temperature distribution can be
monitored by simple manipulation of input power under computer control.
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B. Computation of Power Fractionation for Minimal Standard Deviation of Measured
Intratumoral Temperatures
The mathematical approach we propose for computation of the optimal power fractionation from
the set of estimated SAR and SCR data at each monitored intratumoral site is based upon the
concept that the net SAR from multiple applicators is a linear combination of the contributions to
SAR generated by the individual applicators, which are in turn proportional to the fraction, , of
the total power allocated to each. That is, we assume an incoherent mode of incident power, in
which effects of phase addition and cancellation can be ignored. It is possible, then, to write an
expression for the variance of the intratumoral temperatures (mean squared deviation about the
mean temperature) as a function of the u values. We wish to know the rr values that minimize
this variance. By differentiating the expression for the variance with respect to each u value and
setting the partial derivatives equal to zero, we shall obtain a set of simultaneous linear equations
that can be solved for the unique set of  values giving minimum intratumoral temperature
variation. The derivation is as follows.
Consider, in particular, a situation in which a tumor is heated by k different applicators
arranged in and around the tumor mass, as sketched in Fig. 2. Let the relevant variables be
defined as indicated in the Nomenclature.

Fig. 2. General scheme of multi-applicator hyperthermia treatment assumed in derivation. The
derivation is valid for interstitial as well as the external applicators shown,

6

The rationale for optimal power partitioning is as follows. The net power at point j is

where

Here the first subscript of P represents an applicator from 1 to k and the second subscript of P
represents a point of intratumoral temperature measurement from 1 to n. Recall that Pi,j
represents the SAR at point j if 100 percent of the applied power were delivered continuously
via applicator, i. It is obtained from the change in slope of the temperature time function at point
j as power to applicator i is briefly interrupted, divided by the current value of i. Now
consider a marching solution to the bio-heat equation at point j as

where T= temperature rise above arterial temperature. Letting T0 represent the current
temperature rise, we can estimate the temperature rise at point j after a small time step, dt, as

If power is applied throughout the next diagnostic cycle for m such small time steps in
succession

Passing to the integral as a representation of the sum, and using the trapezoidal rule to
approximate the integral, we have
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and after m steps

Now substituting the cycle time t = m dt, and solving for the temperature rise Tj at the end of
the next diagnostic cycle

where

is a dimensionless indicator of effective perfusion. Now, for simplicity, letting the doubly
subscripted dummy variable

j
and letting

we have
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This is an expression for estimated temperature at the end of the next diagnostic cycle as a
function of the prevailing applied power, effective perfusion, and partitioning of applied power
according to the  values. We seek to pick the  values such that the sum

for points 1 to n within the tumor is minimized, i.e., to choose the  values for most uniform
heating. Because their sum must equal 1, only k – 1 of the  values may be specified
independently.
So let us write Tj and T in terms of the first k – 1 values of , taking

Thus

and

Now, the  values for minimum S will be found from the solution of the k – 1 simultaneous,
normal equations

for the k – 1 unknown  values, where the i-th such equation is
9

Substituting for Tj and T , we have the i-th equation in the set
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Now dividing through by two, setting dS/i = 0, and factoring out the  terms, we have the i-th
equation

There are k – 1 such equations and k – 1 unknown o values corresponding to the indices i = 1 to
k – 1. This terminology can be simplified by writing the above as

for the i-th equation in the series, where
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with i referring to the applicator number and j referring to the point number. The entire set of i
equations is then rendered as

This set of equations is easily solved by numerical methods. The coefficients of the  terms are
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The solution of these linear equations defining the optimal  values can be easily done by a
commercial microcomputer in conjunction with software that computes and stores SAR and SCR
values. Such a task, as opposed to tasks requiring clinical judgment and knowledge of anatomy
and patient geometry, is appropriately accomplished by a digital computer.
C. Computation of Optimal Total Power
Knowing the optimal set of  values, it is then straightforward to compute the recommended
total applied power required to achieve a user-specified mean or minimal target temperature.
This may be done by several methods. A simple and effective strategy that takes advantage of
knowledge of thermal parameters is as follows. Suppose that we find the  values for minimal
standard deviation using the current value of total applied power. The mean estimated
temperature rise, T , at the end of the next diagnostic cycle is

where

as before.
If the new total power is r times the current power, partitioned according to the previously
determined  values, then after power adjustment

Setting T equal to the target temperature rise, we can solve for the power multiplier required as

Thus, we can select the value of r to give the desired mean temperature at the end of the next
diagnostic cycle, which at the same time has minimal standard deviation. The applied power
levels or “control knob settings” for each applicator are then multiplied by (new  old) r to
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obtain the revised power settings predicted to generate a measured intratumoral temperature
distribution that has both minimal standard deviation and on-target mean temperature. If the
therapist prefers to define the target in terms of the minimal sensed intratumoral temperature,
then a similar process can be followed, in which the smallest predicted tumor temperature at the
end of the next diagnostic cycle is substituted for mean temperature.
III. SIMULATIONS OF CONTROLLER PERFORMANCE
We have simulated this proposed control procedure on a mainframe computer, using one
program that solves a one-dimensional version of the bio-heat equation [8] to simulate
temperature changes in tissue and another program that implements the online control algorithm.
Although compiled together, the two programs are logically independent, so that a real
thermometry system and patient or phantom can be substituted for the bio-heat equation model
with only trivial changes to the control software.
A simplified version of the control algorithm is presented in Fig. 3. The program first reads
treatment specifications from a disk file, including such information as the target temperature,
the number of power applicators, and the location of temperature probes (whether in tumor or
normal tissue). Initial conditions of the thermal model are then read from a separate file. Then
the control program loops through diagnostic and power update cycles, as long as the prescribed
treatment time has not elapsed. During a diagnostic cycle, power to each of the multiple
applicators is sequentially turned off for a brief period (e.g., 20 sec). The contribution of each
applicator to net SAR and the effective perfusion at each monitored site are then computed from
slope changes.
In the current implementation, the slope change at a given monitoring site that would occur when
all applicators are turned off is estimated from the sum of slope changes that occur when each
applicator is turned off separately. This feature shortens the diagnostic cycle and eliminates large
dips in temperature associated with total power-off for many configurations.
The computer then calculates the set of  values, defining the unique partitioning of the current
total power that minimizes the standard deviation of predicted intratumoral temperatures at the
end of the next diagnostic cycle. The result is a set of revised “knob settings” that indicate new
values of power to be applied to each applicator.
Next, the control program computes the scale factor, r, required for mean (or if desired,
minimum) intratumoral temperature to equal the target. After a safety check to make sure the
revised knob settings are not excessive, the control software closes the loop by adjusting power
of the modeled applicators to the new knob settings, writes diagnostic information to a record
file, and then, if treatment time is not over, begins another diagnostic cycle.
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Fig. 3. Simplified version of the control algorithm. For explanation, see text.
First we tested how the system works in simulation for a simple example, in which the correct
solution is intuitively obvious. In this case, two applicators deposit power uniformly in two
bands of tumor tissue located at different depths far from the skin surface. One temperature
sensor is located in the middle of each band (Fig. 4). Blood flow to the tissue is uniform and
constant. Because slope-taking algorithms are known to be sensitive to noise, we added a
subroutine to the bio-heat equation model to generate random noise ( 0.05 oC) and then round
off temperatures to the nearest 0.1 oC as a provocative test of the control algorithm. Such noise
and round off are typical in commercial thermometry systems used with clinical hyperthermia
systems.
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Fig. 4. Sketch of the computational model used in initial tests of algorithm performance. Two
bands of tissue are uniformly irradiated. One temperature sensor is located in the middle of each
band. Bands are 3.0 cm wide and separated by 3.0 cm in the calculations.

Fig 5, The performance of a control algorithm in simulation, Blood flow is uniform and constant:
200 ml/min/kg. Initial power partitioning was 150 W/kg to band A (solid line) and 50 W/kg to
band B (dashed line) The power-off interval was 30 sec. Temperatures were sampled every 2
sec. Optimal solution requires that the two temperatures are equal to each other and equal to the
target, here 44 °C. Steady-state portioning of power was 49.9 percent in band A and 50.1 percent
in band B.
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For this simple case, the optimal solution is one in which power is equally partitioned between
the two bands so that the temperature at each sensor is on-target and the standard deviation of
measured temperatures is zero, i.e., the two temperatures are equal to each other and equal to the
target temperature, here 44 oC. The simulation shown in Fig. 5 was begun with unequal powers,
as indicated by the initial slopes: 75 percent (150 W/kg) to band A and 25 percent (50 W/kg) to
band B. After the first diagnostic cycle, the system adjusts power to both applicators and the
temperatures head toward the target. After two diagnostic cycles, the temperatures settle very
near the target. The percentage of total applied power in each band then fluctuates between 49
and 51 percent, very near the correct solution. For comparison, Fig. 6 presents temperature-time
curves for exactly the same situation with the control algorithm turned off. Note that steady-state
temperatures are widely off-target. The simulated noise and round off of the temperature data are
evident.

Fig. 6. Control simulation for Fig. 5. Conditions identical to Fig. 5 with the control algorithm
turned off. Deliberately introduced noise in the temperature data is evident. The vertical sale
identical to that in Fig. 5.
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Fig. 7. Algorithm performance with temperature dependent augmentation of blood flow. In this
simulation, the thermal model updated perfusion as a function of temperature in a linear fashion
up to six-fold over the temperature range from 41 to 46 oC. The power-off interval was 12 sec.
Temperatures were sampled every 2 sec. Despite increased perfusion, the algorithm is able to
encourage tissue temperatures toward the target level of 44 oC. Solid line = band A; dashed line
= band B. Steady-state partitioning of power was 48.4 percent in band A, 51.6 percent in band B.
Performance with Variable Blood Flow: In the previous example, blood flow to the tissue was
kept constant. To illustrate the performance of the control algorithm in the presence of changing
blood flow, Fig. 7 is presented. Now the thermal model updates tissue perfusion as a function of
temperature according to a simplified linear approximation to Song’s results [9], [10]: a six-fold
increase in blood flow over the temperature range from 41 to 46 oC. Note that despite increased
perfusion, the algorithm is able to encourage tissue temperatures toward the target level of 44 oC.
In Fig. 8, the same simulation is repeated with the control algorithm disabled. The temperatures
are divergent and below the target level.
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Fig. 8. Control simulation for Fig 7. Conditions identical to Fig. 7 with the control algorithm
turned off. The temperatures are divergent and off-target. Deliberately introduced noise is
evident.
These preliminary results with a one-dimensional computational model of heated tissue serve to
illustrate the satisfactory performance of the algorithm in the presence of noise, round-off errors,
and variable blood flow. They give us encouragement to pursue development and elaboration of
the system in three dimensional computer models and in tests with living normal and tumor
tissues.
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IV. DISCUSSION
A major improvement in hyperthermia can be expected if spatial temperature distributions could
be achieved similar to that depicted in Fig. 1: The present approach implements an algorithm to
minimize the standard deviation of measured intratumoral temperatures, and in turn, to adjust
total applied power so that the measured tumor temperature distribution is both on-target and
maximally uniform.

Fig. 9. Concept of present versus improved hyperthermia illustrated with histograms. Wide
variation in intratumoral temperatures leads to hot spots and cold spots (a). In an attempt to
minimize complications associated with hot spots, total power is limited such that mean
temperature is less than the target temperature. In improved hyperthermia with multipoint
feedback control, the standard deviation of intratumoral temperatures is reduced, and mean
temperature is on target (b).
20

Dewhirst, Sire, and coworkers have shown a strong correlation between high variability in
intratumoral temperature and poor outcome of clinical hyperthermia treatment of spontaneous
cancers in pet animals [11]. In essence, they found that if the distribution of temperatures within
a tumor shows significant dispersion about its mean value, treatment failures and complications
are likely to result. Cold spots never reach therapeutic temperatures, and so are never treated. Hot
spots lead to complications such as intolerable pain or ulceration of overlying skin. To avoid
complications of hot spots, the therapist is obliged to reduce total applied power, and as a result,
mean tumor temperature is often below target (Fig. 9(a)).
The predictive-adaptive control algorithm described in this paper can make for more uniform
tumor heating, correct for heat-induced changes in blood flow, and permit improved heat therapy
without the moment-to-moment attendance of a physicist, once applicators and temperature
sensors have been correctly placed and the treatment started. Because its implementation is
substantially dependent upon software rather than hardware, the proposed control scheme can
provide great marginal benefit at little marginal cost. Treatment planning is done automatically
under computer control during the course of actual therapy. Changes in blood flow due to heatinduced vasodilation in normal tissues, shunting of flow from tumor to normal tissues, and
perfusion changes due to thermal damage to capillaries and/or microvascular coagulation are
accounted for on a moment-to-moment basis. Formulation of such a dynamic treatment plan
lends itself to computer assistance and control since computer based systems can easily conduct
regular moment-to-moment monitoring of thermal data as well as rapid analysis, calculation, and
adjustment of input power levels.
It is important to point out at this juncture that the system just demonstrated is fundamentally
more sophisticated than one in which total power is servo-controlled to maintain the temperature
of a single sensor at a target level. This latter type of system is quite inadequate for solving the
uniformity problem. Although temperature at a single point in the tumor may be reliably kept on
target, there is no guarantee that cold spots do not exist elsewhere in the tumor, and in particular,
no guarantee that edge temperatures will be sufficient. Our system optimizes not a single
temperature, but the entire sensed temperature distribution. Although more complex than
classical controllers, the present algorithm does not require estimation of the entire three
dimensional temperature distribution. Rather, the controller deals only with temperatures at
measured sites.
Computation time is much less than is required to solve a finite element model: in our experience
to date, a few seconds when performed on an IBM-PC. In principle, it should not be necessary
for the therapist to enter a description of the geometry, location, and extent of the tumor and
surrounding normal tissues, only to identify temperature sensors as being in normal or tumor
tissue. Multipoint thermometry and multiple applicators are required, however, and the greater
the number of each, the more ideal the control is likely to be. The present approach relies upon
the judgment of the therapist about the most reasonable number and placement of temperature
probes for sampling of tumor temperature within clinical constraints. We believe that this will
prove to be a cost-effective and appropriate mix of art and technology in the practical, clinical
setting.
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A potential limitation of the present algorithm is that it does require that the multiplexed power
sources are non-interfering. For certain microwave systems, the assumption of linear
combination of SAR sources will be false. It remains for the algorithm to be tested with different
sources to determine the extent of this limitation. Additional computer simulations using the
three dimensional bio-heat equation are also in order to further define the limitations of the
algorithm. Most important are studies of the effects of the location of temperature sensors and of
more complex geometries, especially situations in which extensive normal tissue intervenes
between power applicators and tumor tissues.
Nevertheless, future implementation of control algorithms of this type, in conjunction with a
multi-applicator hyperthermia systems, may lead both to a lower incidence of complications
caused by hot spots within the treatment field and to a lower incidence of treatment failures
caused by cold spots within the tumor.
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